Beutel, Goodman & Co’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$51K Hold
600
– – ﹤0.01% 136
2026
Q2
$62K Sell
600
-5,265
-90% -$470K ﹤0.01% 134
2026
Q1
$421K Sell
5,865
-5,075
-46% -$391K ﹤0.01% 118
2025
Q4
$868K Sell
10,940
-2,875
-21% -$227K 0.01% 107
2025
Q3
$1.04M Sell
13,815
-1,825
-12% -$125K 0.01% 104
2025
Q2
$1.08M Sell
15,640
-3,600
-19% -$236K 0.01% 101
2025
Q1
$1.3M Buy
+19,240
New +$1.15M 0.01% 101

Other funds holding CVS

Beutel, Goodman & Co's CVS Position: Q3 2026 in Review

Beutel, Goodman & Co held its CVS Health (CVS) position steady in Q3 2026 at 600 shares worth $51K. The position accounts for ﹤0.01% of the portfolio, ranked #136.

Beutel, Goodman & Co first reported a position in CVS in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.3M in Q1 2025. 1,998 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • Beutel, Goodman & Co held 600 shares of CVS Health worth $51K as of Q3 2026.
  • Beutel, Goodman & Co left its CVS Health share count unchanged in Q3 2026.
  • CVS Health made up ﹤0.01% of Beutel, Goodman & Co's portfolio in Q3 2026, its #136 holding.
  • Beutel, Goodman & Co first reported a position in CVS Health in Q1 2025 and has held it in 7 quarters since.
  • Beutel, Goodman & Co's CVS Health position peaked at $1.3M in Q1 2025.
  • 1,998 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Beutel, Goodman & Co's 13F filing for Q3 2026, filed 4 Nov 2026.